Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Citrin Website

Deborah E. Citrin, M.D.

Selected Publications

1)  Citrin DE, Shankavaram U, Horton JA, Shield W, Zhao S, Asano H, White A, Sowers A, Thetford A, Chung EJ.
Role of Type II Pneumocyte Senescence in Radiation-Induced Lung Fibrosis.
J. Natl. Cancer Inst. 105: 1474-84, 2013.
[Journal]
2)  Horton JA, Hudak KE, Chung EJ, White AO, Scroggins BT, Burkeen JF, Citrin DE.
Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation.
Stem Cells. 31: 2231-41, 2013.
[Journal]
3)  Urick ME, Chung EJ, Shield WP, Gerber N, White A, Sowers A, Thetford A, Camphausen K, Mitchell J, Citrin DE.
Enhancement of 5-Fluorouracil-induced In Vitro and In Vivo Radiosensitization with MEK Inhibition.
Clin Cancer Res. 17: 5038-47, 2011.
[Journal]
4)  Chung EJ, Brown AP, Asano H, Mandler M, Burgan WE, Carter D, Camphausen K, Citrin D.
In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase.
Clin. Cancer Res. 15: 3050-7, 2009.
[Journal]
5)  Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB.
Radioprotectors and mitigators of radiation-induced normal tissue injury.
Oncologist. 15: 360-71, 2010.
[Journal]
6)  Prieto DA, Johann DJ, Wei BR, Ye X, Chan KC, Nissley DV, Simpson RM, Citrin DE, Mackall CL, Linehan WM, Blonder J.
Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.
Biomark Med. 8: 269-86, 2014.
[Journal]
7)  Tseng J, Citrin DE, Waldman M, White DE, Rosenberg SA, Yang JC.
Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation.
Cancer. 120: 1426-32, 2014.
[Journal]
8)  Citrin D, Camphausen KA.
Biomarkers for prostate cancer: who will benefit from local treatment, who harbors occult systemic disease and who needs treatment at all?.
Biomark Med. 7: 823-5, 2013.
[Journal]
9)  Citrin D, Hudak K, Camphausen KA.
Biomarkers to guide therapy or surveillance for prostate cancer.
Biomark Med. 7: 827-9, 2013.
[Journal]
10)  Horton JA, Chung EJ, Hudak KE, Sowers A, Thetford A, White AO, Mitchell JB, Citrin DE.
Inhibition of radiation-induced skin fibrosis with imatinib.
Int. J. Radiat. Biol. 89: 162-70, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 6/17/2014.